8-K item 3.01
Exchange deficiency notices
Open Nasdaq and NYSE listing deficiency notices and their cure deadlines as stated in the filing.
Open notices by deadline 199
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| SkinHealth Systems | Stock under $1Nasdaq rule 5550(a)(2) | May 12, 2026 (8-K filed) | Nov 4, 2026 | 8-K item 3.01 |
| Skye Bioscience | Stockholders' equity too lowNasdaq rule 5450(b)(1)(A) | May 15, 2026 (8-K filed) | Nov 9, 2026 | 8-K item 3.01 |
| Rani Therapeutics Holdings | Stock under $1Nasdaq rule 5450(a)(1) | May 11, 2026 | Nov 9, 2026 | 8-K item 3.01 |
| Fathom Holdings | Late filingNasdaq rule 5250(c)(1) | May 22, 2026 | Nov 11, 2026 | 8-K item 3.01 |
| GT Biopharma | Stock under $1Nasdaq rule 5550(a)(2) | May 20, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Rci Hospitality Holdings | Late filingNasdaq rule 5250(c)(1) | May 20, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Socket Mobile | Stock under $1Nasdaq rule 5550(a)(2) | May 20, 2026 (8-K filed) | Nov 16, 2026 | 8-K item 3.01 |
| Clean Energy Technologies | Late filingNasdaq rule 5250(c)(1) | May 26, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Singularity Future Technology | Stock under $1Nasdaq rule 5550(a)(2) | Nov 19, 2025 | Nov 16, 2026 | 8-K item 3.01 |
| American Resources | Late filingNasdaq rule 5250(c)(1) | Oct 7, 2026 (8-K filed) | Nov 16, 2026 | 8-K item 3.01 |
| Cloudastructure | Late filingNasdaq rule 5250(c)(1) | May 26, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Envoy Medical | Stock under $1Nasdaq rule 5550(a)(2) | May 19, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Richtech Robotics | Late filingNasdaq rule 5250(c)(1) | May 22, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Medicus Pharma | Market value too lowNasdaq rule 5550(b)(2) | May 20, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| TEN Holdings | Stockholders' equity too lowNasdaq rule 5550(b)(1) | May 26, 2026 (8-K filed) | Nov 22, 2026 | 8-K item 3.01 |
| iSpecimen | Listing ruleNasdaq rule 5550(b) | Sep 8, 2026 | Nov 25, 2026 | 8-K item 3.01 |
| EnerSyn Global | Stockholders' equity too lowNasdaq rule 5550(b)(1) | May 29, 2026 (8-K filed) | Nov 25, 2026 | 8-K item 3.01 |
| Research Frontiers | Stock under $1Nasdaq rule 5550(a)(2) | Jun 2, 2026 | Nov 30, 2026 | 8-K item 3.01 |
| aTYR PHARMA | Stock under $1Nasdaq rule 5550(a)(2) | Jun 3, 2026 | Nov 30, 2026 | 8-K item 3.01 |
| Cardlytics | Stock under $1Nasdaq rule 5550(a)(2) | Jun 3, 2026 | Nov 30, 2026 | 8-K item 3.01 |
| Jasper Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jun 3, 2026 | Nov 30, 2026 | 8-K item 3.01 |
| Arrive AI | Stock under $1Nasdaq rule 5450(a)(1) | Jun 2, 2026 | Nov 30, 2026 | 8-K item 3.01 |
| Professional Diversity Network | Stock under $1Nasdaq rule 5550(a)(2) | Jun 5, 2026 | Dec 2, 2026 | 8-K item 3.01 |
| Vivos Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jun 5, 2026 | Dec 2, 2026 | 8-K item 3.01 |
| Soligenix | Stock under $1Nasdaq rule 5550(a)(2) | Jun 10, 2026 | Dec 7, 2026 | 8-K item 3.01 |
| Celularity | Market value too lowNasdaq rule 5550(b)(2) | Jun 9, 2026 | Dec 7, 2026 | 8-K item 3.01 |
| Stratum Holdings | Late filingNasdaq rule 5250(c)(1) | Jun 4, 2026 | Dec 7, 2026 | 8-K item 3.01 |
| Cyabra | Public float too lowNasdaq rule 5450(b)(2)(C) | Jun 12, 2026 (8-K filed) | Dec 7, 2026 | 8-K item 3.01 |
| OFA Group | Stock under $1Nasdaq rule 5550(a)(2) | Jun 9, 2026 | Dec 7, 2026 | 8-K item 3.01 |
| Adagio Medical Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Jun 12, 2026 | Dec 9, 2026 | 8-K item 3.01 |
| Algorhythm Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Jun 16, 2026 | Dec 14, 2026 | 8-K item 3.01 |
| Definitive Healthcare | Stock under $1Nasdaq rule 5450(a)(1) | Jun 18, 2026 | Dec 15, 2026 | 8-K item 3.01 |
| Soar AI | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Jun 3, 2026 | Dec 17, 2026 | 8-K item 3.01 |
| SolarMax Technology | Late filingNasdaq rule 5250(c)(1) | Aug 20, 2026 | Dec 21, 2026 | 8-K item 3.01 |
| Heron Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jun 25, 2026 | Dec 22, 2026 | 8-K item 3.01 |
| AI Financial | Stock under $1Nasdaq rule 5550(a)(2) | Jul 1, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| Cytosorbents | Market value too lowNasdaq rule 5550(b)(2) | Jun 29, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| RenovoRx | Stock under $1Nasdaq rule 5550(a)(2) | Jul 2, 2026 (8-K filed) | Dec 28, 2026 | 8-K item 3.01 |
| FingerMotion | Stock under $1Nasdaq rule 5550(a)(2) | Jun 30, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| CISO Global | Stock under $1Nasdaq rule 5550(a)(2) | Dec 30, 2025 | Dec 28, 2026 | 8-K item 3.01 |
| HeartBeam | Stock under $1Nasdaq rule 5550(a)(2) | Jul 2, 2026 (8-K filed) | Dec 28, 2026 | 8-K item 3.01 |
| Linkhome Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Jun 29, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| Callan JMB | Stock under $1Nasdaq rule 5550(a)(2) | Jun 29, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| Breeze Acquisition Corp. II | Late filingNasdaq rule 5250(c)(1) | Aug 20, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| Prairie Operating | Stock under $1Nasdaq rule 5550(a)(2) | Jul 2, 2026 | Dec 29, 2026 | 8-K item 3.01 |
| Borealis Foods | Market value too lowNasdaq rule 5550(b)(2) | Jul 2, 2026 | Dec 29, 2026 | 8-K item 3.01 |
| Dragonfly Energy Holdings | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 20, 2026 | Dec 31, 2026 | 8-K item 3.01 |
| Pluri | Market value too lowNasdaq rule 5550(b)(2) | Jul 7, 2026 | Jan 4, 2027 | 8-K item 3.01 |
| Quanome Technologies | Stock under $1Nasdaq rule 5550(a)(2) | Jul 10, 2026 (8-K filed) | Jan 4, 2027 | 8-K item 3.01 |
| Actuate Therapeutics | Market value too lowNasdaq rule 5450(b)(2)(A) | Jul 15, 2026 | Jan 11, 2027 | 8-K item 3.01 |
| Our Bond | Stock under $1Nasdaq rule 5450(a)(1) | Jul 14, 2026 | Jan 11, 2027 | 8-K item 3.01 |
| Fold Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Jul 17, 2026 (8-K filed) | Jan 11, 2027 | 8-K item 3.01 |
| Fly-E Group | Late filingNasdaq rule 5250(c)(1) | Jul 21, 2026 | Jan 11, 2027 | 8-K item 3.01 |
| 20/20 Biolabs | Stock under $1Nasdaq rule 5550(a)(2) | Sep 3, 2026 | Jan 13, 2027 | 8-K item 3.01 |
| InspireMD | Stock under $1Nasdaq rule 5550(a)(2) | Jul 17, 2026 | Jan 13, 2027 | 8-K item 3.01 |
| VivoSim Labs | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Jul 20, 2026 | Jan 16, 2027 | 8-K item 3.01 |
| Odyssey Marine Exploration | Stock under $1Nasdaq rule 5550(a)(2) | Jul 24, 2026 (8-K filed) | Jan 19, 2027 | 8-K item 3.01 |
| Peraso | Stock under $1Nasdaq rule 5550(a)(2) | Jul 21, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Oncolytics Biotech | Stock under $1Nasdaq rule 5550(a)(2) | Jul 24, 2026 (8-K filed) | Jan 19, 2027 | 8-K item 3.01 |
| Standard Biotools | Stock under $1Nasdaq rule 5450(a)(1) | Jul 22, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Liqtech International | Stock under $1Nasdaq rule 5550(a)(2) | Jul 21, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Cypherpunk Technologies | Stock under $1Nasdaq rule 5550(a)(2) | Jul 21, 2026 (8-K filed) | Jan 19, 2027 | 8-K item 3.01 |
| Celularity | Stock under $1Nasdaq rule 5450(a)(1) | Jul 23, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Aprea Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jul 23, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Arrive AI | Public float too lowNasdaq rule 5450(b)(2)(C) | Jul 21, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Invivyd | Stock under $1Nasdaq rule 5450(a)(1) | Jul 23, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Amass Brands | Market value too lowNasdaq rule 5450(b)(2)(A) | Jul 22, 2026 | Jan 19, 2027 | 8-K item 3.01 |
| Foxx Development Holdings | Market value too lowNasdaq rule 5550(b)(2) | Jul 29, 2026 (8-K filed) | Jan 19, 2027 | 8-K item 3.01 |
| Fusemachines | Public float too lowNasdaq rule 5450(b)(2)(C) | Jul 24, 2026 | Jan 20, 2027 | 8-K item 3.01 |
| Traws Pharma | Stock under $1Nasdaq rule 5550(a)(2) | Jul 29, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| Blink Charging | Stock under $1Nasdaq rule 5550(a)(2) | Jul 28, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| Loop Industries | Market value too lowNasdaq rule 5450(b)(2)(A) | Jul 24, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| DocGo | Stock under $1Nasdaq rule 5550(a)(2) | Jul 28, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| Context Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jul 29, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| MIRA Pharmaceuticals | Stock under $1Nasdaq rule 5550(a)(2) | Jul 27, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| PDS Biotechnology | Stock under $1Nasdaq rule 5550(a)(2) | Jul 30, 2026 | Jan 26, 2027 | 8-K item 3.01 |
| Upexi | Stock under $1Nasdaq rule 5550(a)(2) | Jul 30, 2026 | Jan 26, 2027 | 8-K item 3.01 |
| Upland Software | Listing ruleNasdaq rule 5450(b) | Jul 31, 2026 | Jan 27, 2027 | 8-K item 3.01 |
| Humacyte | Stock under $1Nasdaq rule 5450(a)(1) | Jul 31, 2026 | Jan 27, 2027 | 8-K item 3.01 |
| Endovia Health Sciences | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Jul 8, 2026 | Jan 29, 2027 | 8-K item 3.01 |
| HeartSciences | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 4, 2026 | Jan 31, 2027 | 8-K item 3.01 |
| Eureka Acquisition | Listing ruleNasdaq rule 5450(a)(4) | Oct 26, 2026 | Jan 31, 2027 | 8-K item 3.01 |
| Destination XL Group | Stock under $1Nasdaq rule 5450(a)(1) | Aug 4, 2026 | Feb 1, 2027 | 8-K item 3.01 |
| Vistagen Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Aug 5, 2026 (8-K filed) | Feb 1, 2027 | 8-K item 3.01 |
| Arcadia Biosciences | Stock under $1Nasdaq rule 5550(a)(2) | Aug 4, 2026 | Feb 1, 2027 | 8-K item 3.01 |
| Barfresh Food Group | Market value too lowNasdaq rule 5550(b)(2) | Aug 3, 2026 | Feb 1, 2027 | 8-K item 3.01 |
| Eightco Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Aug 7, 2026 (8-K filed) | Feb 1, 2027 | 8-K item 3.01 |
| Neonode | Stock under $1Nasdaq rule 5550(a)(2) | Aug 7, 2026 (8-K filed) | Feb 2, 2027 | 8-K item 3.01 |
| Elutia | Stock under $1Nasdaq rule 5550(a)(2) | Aug 6, 2026 | Feb 2, 2027 | 8-K item 3.01 |
| Rocket One | Stock under $1Nasdaq rule 5550(a)(2) | Aug 6, 2026 | Feb 2, 2027 | 8-K item 3.01 |
| Avalanche Treasury | Stock under $1Nasdaq rule 5550(a)(2) | Aug 6, 2026 | Feb 2, 2027 | 8-K item 3.01 |
| Teads Holding | Stock under $1Nasdaq rule 5450(a)(1) | Aug 11, 2026 | Feb 8, 2027 | 8-K item 3.01 |
| Citius Pharmaceuticals | Stock under $1Nasdaq rule 5550(a)(2) | Aug 17, 2026 | Feb 8, 2027 | 8-K item 3.01 |
| BullFrog AI Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Aug 20, 2026 (8-K filed) | Feb 8, 2027 | 8-K item 3.01 |
| Worksport | Stock under $1Nasdaq rule 5550(a)(2) | Aug 13, 2026 | Feb 9, 2027 | 8-K item 3.01 |
| Netcapital | Late filingNasdaq rule 5250(c)(1) | Sep 21, 2026 | Feb 9, 2027 | 8-K item 3.01 |
| Circle8 Group | Stock under $1Nasdaq rule 5450(a)(1) | Aug 13, 2026 | Feb 9, 2027 | 8-K/A item 3.01 |
| Maison Solutions | Late filingNasdaq rule 5250(c)(1) | Sep 23, 2026 | Feb 9, 2027 | 8-K item 3.01 |
| Ocean Power Technologies | Late filingNYSE American rule 1007 | Aug 14, 2026 | Feb 13, 2027 | 8-K item 3.01 |
| Skye Bioscience | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 19, 2026 (8-K filed) | Feb 14, 2027 | 8-K item 3.01 |
| authID | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 18, 2026 | Feb 14, 2027 | 8-K item 3.01 |
| Roman DBDR Acquisition Corp. II | Too few public holdersNasdaq rule 5450(a)(2) | Aug 19, 2026 | Feb 15, 2027 | 8-K item 3.01 |
| BEST SPAC I Acquisition | Market value too lowNasdaq rule 5550(b)(2) | Aug 19, 2026 | Feb 15, 2027 | 8-K item 3.01 |
| BioCardia | Stock under $1Nasdaq rule 5550(a)(2) | Aug 19, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| VivoSim Labs | Stock under $1Nasdaq rule 5550(a)(2) | Aug 17, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| BioRestorative Therapies | Late filingNasdaq rule 5250(c)(1) | Aug 21, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Mereo BioPharma Group | Stock under $1Nasdaq rule 5550(a)(2) | Aug 18, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Estrella Immunopharma | Stock under $1Nasdaq rule 5550(a)(2) | Aug 21, 2026 (8-K filed) | Feb 16, 2027 | 8-K item 3.01 |
| Dragonfly Energy Holdings | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 20, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Borealis Foods | Late filingNasdaq rule 5250(c)(1) | Jun 30, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Global Interactive Technologies | Late filingNasdaq rule 5250(c)(1) | Aug 20, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Rising Dragon Acquisition | Market value too lowNasdaq rule 5550(b)(2) | Aug 20, 2026 (8-K filed) | Feb 16, 2027 | 8-K item 3.01 |
| Rein Therapeutics | Listing ruleNasdaq rule 5550(a)(1) | Aug 21, 2026 | Feb 17, 2027 | 8-K item 3.01 |
| CaliberCos | Stock under $1Nasdaq rule 5550(a)(2) | Aug 26, 2026 (8-K filed) | Feb 17, 2027 | 8-K item 3.01 |
| Valor Energy | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 21, 2026 | Feb 17, 2027 | 8-K item 3.01 |
| Fathom Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Aug 25, 2026 (8-K filed) | Feb 17, 2027 | 8-K item 3.01 |
| Aimei Health Technology | Market value too lowNasdaq rule 5450(b)(2)(A) | Aug 25, 2026 (8-K filed) | Feb 17, 2027 | 8-K item 3.01 |
| Pantages Capital Acquisition | Market value too lowNasdaq rule 5450(b)(2)(A) | Aug 21, 2026 | Feb 17, 2027 | 8-K item 3.01 |
| My Size | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 25, 2026 | Feb 21, 2027 | 8-K item 3.01 |
| XTI Aerospace | Late filingNasdaq rule 5250(c)(1) | Aug 26, 2026 | Feb 22, 2027 | 8-K item 3.01 |
| Shuttle Pharmaceuticals Holdings | Late filingNasdaq rule 5250(c)(1) | Aug 28, 2026 | Feb 22, 2027 | 8-K item 3.01 |
| authID | Stock under $1Nasdaq rule 5550(a)(2) | Aug 27, 2026 | Feb 23, 2027 | 8-K item 3.01 |
| TScan Therapeutics | Stock under $1Nasdaq rule 5450(a)(1) | Aug 27, 2026 | Feb 23, 2027 | 8-K item 3.01 |
| Senti Biosciences Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Aug 27, 2026 | Feb 23, 2027 | 8-K item 3.01 |
| ARC Group Acquisition I | Listing ruleNasdaq rule 5452(b)(C) | Aug 27, 2026 | Feb 23, 2027 | 8-K item 3.01 |
| IRulya Therapeutics | Stockholders' equity too lowNasdaq rule 5450(b)(1)(A) | Aug 31, 2026 | Feb 27, 2027 | 8-K item 3.01 |
| Nexentis Technologies | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Aug 31, 2026 | Feb 27, 2027 | 8-K item 3.01 |
| Iveda Solutions | Stock under $1Nasdaq rule 5550(a)(2) | Sep 2, 2026 | Mar 1, 2027 | 8-K item 3.01 |
| Aterian | Stock under $1Nasdaq rule 5550(a)(2) | Sep 2, 2026 | Mar 1, 2027 | 8-K item 3.01 |
| Estrella Immunopharma | Market value too lowNasdaq rule 5550(b)(2) | Sep 8, 2026 (8-K filed) | Mar 1, 2027 | 8-K item 3.01 |
| VenHub Global | Stock under $1Nasdaq rule 5450(a)(1) | Sep 1, 2026 | Mar 1, 2027 | 8-K item 3.01 |
| Greenland Technologies Holding | Stock under $1Nasdaq rule 5550(a)(2) | Sep 10, 2026 | Mar 8, 2027 | 8-K item 3.01 |
| House of Doge | Stock under $1Nasdaq rule 5550(a)(2) | Sep 9, 2026 | Mar 8, 2027 | 8-K/A item 3.01 |
| Bone Biologics | Stock under $1Nasdaq rule 5550(a)(2) | Sep 10, 2026 | Mar 9, 2027 | 8-K item 3.01 |
| Stardust Power | Market value too lowNasdaq rule 5550(b)(2) | Oct 19, 2026 (8-K filed) | Mar 10, 2027 | 8-K item 3.01 |
| Stardust Power | Stock under $1Nasdaq rule 5550(a)(2) | Sep 17, 2026 (8-K filed) | Mar 10, 2027 | 8-K item 3.01 |
| InMed Pharmaceuticals | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Sep 16, 2026 | Mar 15, 2027 | 8-K item 3.01 |
| Filana Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Sep 17, 2026 | Mar 16, 2027 | 8-K item 3.01 |
| BeyondSpring | Stock under $1Nasdaq rule 5550(a)(2) | Sep 17, 2026 | Mar 16, 2027 | 8-K item 3.01 |
| Hyperfine | Stock under $1Nasdaq rule 5450(a)(1) | Sep 17, 2026 | Mar 16, 2027 | 8-K item 3.01 |
| Fusemachines | Stock under $1Nasdaq rule 5450(a)(1) | Sep 18, 2026 | Mar 17, 2027 | 8-K item 3.01 |
| Hain Celestial Group | Stock under $1Nasdaq rule 5450(a)(1) | Sep 22, 2026 | Mar 22, 2027 | 8-K item 3.01 |
| SurgePays | Stockholders' equity too lowNasdaq rule 5550(b)(1) | Sep 28, 2026 | Mar 22, 2027 | 8-K item 3.01 |
| SANUWAVE Health | Market value too lowNasdaq rule 5450(b)(2)(A) | Sep 25, 2026 (8-K filed) | Mar 22, 2027 | 8-K item 3.01 |
| Future Money Acquisition | Late filingNasdaq rule 5250(c)(1) | Sep 25, 2026 (8-K filed) | Mar 22, 2027 | 8-K item 3.01 |
| Dyadic International | Stock under $1Nasdaq rule 5550(a)(2) | Sep 25, 2026 | Mar 24, 2027 | 8-K item 3.01 |
| Outlook Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Sep 30, 2026 (8-K filed) | Mar 24, 2027 | 8-K item 3.01 |
| Lantern Pharma | Market value too lowNasdaq rule 5550(b)(2) | Oct 1, 2026 (8-K filed) | Mar 24, 2027 | 8-K item 3.01 |
| Solesence | Stock under $1Nasdaq rule 5550(a)(2) | Sep 29, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| XCel Brands | Reason not stated | Oct 2, 2026 (8-K filed) | Mar 29, 2027 | 8-K item 3.01 |
| Dare Bioscience | Stock under $1Nasdaq rule 5550(a)(2) | Sep 28, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Virtuix Holdings | Market value too lowNasdaq rule 5450(b)(2)(A) | Oct 6, 2026 (8-K filed) | Mar 29, 2027 | 8-K item 3.01 |
| BeyondSpring | Market value too lowNasdaq rule 5550(b)(2) | Sep 29, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Blaize Holdings | Stock under $1Nasdaq rule 5450(a)(1) | Sep 28, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Gaxos.ai | Stock under $1Nasdaq rule 5550(a)(2) | Sep 28, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Aether Holdings | Annual meeting not heldNasdaq rule 5620(a) | Oct 12, 2026 | Mar 29, 2027 | 8-K item 3.01 |
| Azitra | Stockholders' equity too lowNYSE American rule 1003(a)(iii) | Mar 13, 2026 | Apr 1, 2027 | 8-K item 3.01 |
| Azitra | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | Dec 16, 2025 | Apr 1, 2027 | 8-K item 3.01 |
| Xwell | Stock under $1Nasdaq rule 5550(a)(2) | Oct 20, 2026 (8-K filed) | Apr 5, 2027 | 8-K item 3.01 |
| Streamex | Stock under $1Nasdaq rule 5550(a)(2) | Oct 7, 2026 | Apr 5, 2027 | 8-K item 3.01 |
| Innovative Eyewear | Stock under $1Nasdaq rule 5550(a)(2) | Oct 15, 2026 (8-K filed) | Apr 7, 2027 | 8-K item 3.01 |
| Amass Brands | Stock under $1Nasdaq rule 5450(a)(1) | Oct 9, 2026 | Apr 7, 2027 | 8-K item 3.01 |
| eHealth | Stock under $1Nasdaq rule 5450(a)(1) | Oct 14, 2026 | Apr 12, 2027 | 8-K item 3.01 |
| Bridgeline Digital | Stock under $1Nasdaq rule 5550(a)(2) | Oct 14, 2026 | Apr 12, 2027 | 8-K item 3.01 |
| Canopy Growth | Stock under $1Nasdaq rule 5450(a)(1) | Oct 14, 2026 | Apr 12, 2027 | 8-K item 3.01 |
| Lucid Diagnostics | Stock under $1Nasdaq rule 5550(a)(2) | Oct 16, 2026 (8-K filed) | Apr 12, 2027 | 8-K item 3.01 |
| Cyngn | Stock under $1Nasdaq rule 5550(a)(2) | Oct 14, 2026 | Apr 12, 2027 | 8-K item 3.01 |
| Health In Tech | Board or audit committee rulesNasdaq rule 5605(b)(1) | Oct 12, 2026 | Apr 12, 2027 | 8-K item 3.01 |
| IT Tech Packaging | Late filingNYSE American rule 1007 | Oct 7, 2026 | Apr 15, 2027 | 8-K item 3.01 |
| ARC Group Securities Acquisition I | Listing ruleNasdaq rule 5452(b)(C) | Oct 20, 2026 | Apr 18, 2027 | 8-K item 3.01 |
| Century Casinos | Market value too lowNasdaq rule 5550(b)(2) | Oct 19, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| Akebia Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Oct 21, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| SenesTech | Stock under $1Nasdaq rule 5550(a)(2) | Oct 20, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| Laser Photonics | Stock under $1Nasdaq rule 5550(a)(2) | Oct 23, 2026 (8-K filed) | Apr 19, 2027 | 8-K item 3.01 |
| Nextnrg | Market value too lowNasdaq rule 5550(b)(2) | Oct 21, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| SHF Holdings | Stock under $1Nasdaq rule 5550(a)(2) | Oct 20, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| Zeo Energy | Stock under $1Nasdaq rule 5550(a)(2) | Oct 22, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| Advasa Holdings | Stock under $1Nasdaq rule 5450(a)(1) | Oct 21, 2026 | Apr 19, 2027 | 8-K item 3.01 |
| Milestone Pharmaceuticals | Stock under $1Nasdaq rule 5450(a)(1) | Oct 23, 2026 | Apr 21, 2027 | 8-K item 3.01 |
| Innventure | Stock under $1Nasdaq rule 5450(a)(1) | Oct 23, 2026 (8-K filed) | Apr 21, 2027 | 8-K item 3.01 |
| Actuate Therapeutics | Stock under $1Nasdaq rule 5450(a)(1) | Oct 28, 2026 | Apr 26, 2027 | 8-K item 3.01 |
| Rekor Systems | Stock under $1Nasdaq rule 5550(a)(2) | Oct 27, 2026 | Apr 26, 2027 | 8-K item 3.01 |
| Alset | Stock under $1Nasdaq rule 5550(a)(2) | Oct 28, 2026 | Apr 26, 2027 | 8-K item 3.01 |
| Neumora Therapeutics | Stock under $1Nasdaq rule 5450(a)(1) | Oct 26, 2026 | Apr 26, 2027 | 8-K item 3.01 |
| Bridger Aerospace Group Holdings | Stock under $1Nasdaq rule 5450(a)(1) | Oct 30, 2026 (8-K filed) | Apr 26, 2027 | 8-K item 3.01 |
| Game Your Game | Stock under $1Nasdaq rule 5550(a)(2) | Oct 27, 2026 | Apr 26, 2027 | 8-K item 3.01 |
| Ribbon Acquisition | Market value too lowNasdaq rule 5550(b)(2) | Oct 30, 2026 | Apr 28, 2027 | 8-K item 3.01 |
| Planet Green Holdings | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Feb 18, 2026 | Jun 8, 2027 | 8-K item 3.01 |
| Volitionrx | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Feb 9, 2026 | Aug 6, 2027 | 8-K item 3.01 |
| Cryo Cell International | Reason not stated | May 6, 2026 | Sep 9, 2027 | 8-K item 3.01 |
| Tessera Defense & Homeland Security | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Jun 12, 2026 (8-K filed) | Sep 25, 2027 | 8-K item 3.01 |
| Matinas BioPharma Holdings | Stockholders' equity too lowNYSE American rule 1003(a)(iii) | Jun 24, 2026 | Oct 2, 2027 | 8-K item 3.01 |
| Picard Medical | Stockholders' equity too lowNYSE American rule 1003(a)(i) | May 15, 2026 | Nov 8, 2027 | 8-K item 3.01 |
| Picard Medical | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | May 8, 2026 | Nov 8, 2027 | 8-K item 3.01 |
| Actinium Pharmaceuticals | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | Aug 14, 2026 (8-K filed) | Nov 27, 2027 | 8-K item 3.01 |
| Reed's | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Aug 12, 2026 | Nov 29, 2027 | 8-K item 3.01 |
| Reed's | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | May 29, 2026 | Nov 29, 2027 | 8-K item 3.01 |
| Oragenics | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | Aug 26, 2026 | Feb 25, 2028 | 8-K item 3.01 |
| Southland Holdings | Stockholders' equity too lowNYSE American rule 1003(a)(i) | Sep 25, 2026 (8-K filed) | Mar 23, 2028 | 8-K item 3.01 |
Delisted or bankrupt 1
A ticker ending in Q marks a company in bankruptcy or off its exchange, so these notices are not open, curable deficiencies.
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| Synergy CHC | Stock under $1Nasdaq rule 5550(a)(2) | May 15, 2026 | Nov 11, 2026 | 8-K item 3.01 |
Data through Nov 2, 2026, the newest 8-K item 3.01 SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. Not investment advice. Not affiliated with the U.S. SEC. Listing deadlines on the calendar · All screens